T2 Biosystems, Inc. Announces $50M Credit Facility
Jan 05, 2017 11:30 am UTC| Business
-- Retiring Former Debt Facility; Significantly Decreases Near-Term Cash Needs -- LEXINGTON, Mass., Jan. 05, 2017 -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products that improve...
ChromaDex Opens New State-of-the-Art Research and Development Center in Longmont
Jan 05, 2017 11:30 am UTC| Business
IRVINE, Calif., Jan. 05, 2017 -- Today, ChromaDex Corporation (https://www.chromadex.com/) (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for...
Genocea Announces Positive 6-Month Results from GEN-003 Phase 2b Clinical Trial
Jan 05, 2017 11:30 am UTC| Business
- Trial meets statistical significance vs. placebo for multiple clinical endpoints through six months - - End of Phase 2 meeting with FDA expected in Q1 2017 - - Phase 3 launch expected in Q4 2017 - - GEN-003 has...
Park Electrochemical Corp. Reports Third Quarter Results
Jan 05, 2017 11:30 am UTC| Business
MELVILLE, N.Y., Jan. 05, 2017 -- Park Electrochemical Corp. (NYSE:PKE) reported net sales of $26,462,000 for the 2017 fiscal year’s third quarter ended November 27, 2016 compared to net sales of $34,323,000 for last...
Jan 05, 2017 11:09 am UTC| Business
Dublin, Jan. 05, 2017 -- Research and Markets has announced the addition of the "Gas Sensors and Gas Metering: Applications and Markets" report to their offering. The global market...
CF&B Communication : Selected Midcaps meet German institutional investors
Jan 05, 2017 11:05 am UTC| Business
(Frankfurt) - On the 2 February, CFB Communication will be organizing its 10th edition of the "Frankfurt Midcap Event", where selected Midcaps travelling to European financial capitals will make a stop in Frankfurt to...
Cesca Announces FDA Approval of IDE Supplement for Phase III Clinical Trial
Jan 05, 2017 11:00 am UTC| Business
RANCHO CORDOVA, Calif., Jan. 05, 2017 -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cellular processing and point-of-care autologous cell-based therapies, announced today that the Company...